Aberrant DNA methylation on chromosome 16 is an early event in hepatocarcinogenesis

Japanese Journal of Cancer Research

Volumn 87, Issue 12, 1996, Pages 1210-1217

  Kanai, Yae ^a   Ushijima, Saori ^a   Tsuda, Hitoshi ^a   Sakamoto, Michiie ^a   Sugimura, Takashi ^a   Hirohashi, Setsuo ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Hepatocellular carcinoma; Loss of heterozygosity; Multistage carcinogenesis

Indexed keywords

RESTRICTION ENDONUCLEASE; TYROSINE AMINOTRANSFERASE;

ARTICLE; CHROMOSOME 16; CHRONIC HEPATITIS; CLINICAL ARTICLE; DNA METHYLATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PRIORITY JOURNAL;

EID: 0030476367     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb03135.x     Document Type: Article

References (55)

1. Tsuda, H., Hirohashi, S., Shimosato, Y., Terada, M. and Hasegawa, H. Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma. Gastroenterology, 95, 1664-1666 (1988).
2. Yasui, H., Hino, O., Ohtake, K., Machinami, R. and Kitagawa, T. Clonal growth of hepatitis B virus-integrated hepatocytes in cirrhotic liver nodule. Cancer Res., 52, 6810-6814 (1992).
3. Kanai, T., Hirohashi, S., Upton, M. P., Noguchi, M., Kishi, K., Makuuchi, M., Yamasaki, S., Hasegawa, H., Takayasu, K., Moriyama, N. and Shimosato, Y. Pathology of small hepatocellular carcinoma: a proposal for a new gross classification. Cancer, 60, 810-819 (1987).
4. Sakamoto, M., Hirohashi, S. and Shimosato, Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum. Pathol., 22, 172-178 (1991).
5. Wang, H. P. and Rogler, C. E. Deletion in human chromosome arm 11p and 13q in primary hepatocellular carcinoma. Cytogenet. Cell Genet., 48, 72-78 (1988).
6. Buetow, K. H., Murray, J. C., Israel, J. L., London, W. T., Smith, M., Kew, M., Blanquest, V., Brechet, C., Redeker, A. and Govindarajah, S. Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA, 86, 8852-8856 (1989).
7. Tsuda, H., Zhang, W., Shimosato, Y., Yokota, J., Terada, M., Sugimura, T., Miyamura, T. and Hirohashi, S. Allelic loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA, 87, 6791-6794 (1990).
8. Zhang, W., Hirohashi, S., Tsuda, H., Shimosato, Y., Yokota, J., Terada, M. and Sugimura, T. Frequent loss of heterozygosity on chromosome 16 and 4 in human hepatocellular carcinoma. Jpn. J. Cancer Res., 81, 108-111 (1990).
9. Fujimori, M., Tokino, T., Hino, O., Kitagawa, T., Imamura, T., Okamoto, E., Mitsunobu, M., Ishikawa, T., Nakagama, H., Harada, H., Yagura, M., Matsubara, K. and Nakamura, Y. Allelotype study of primary hepatocellular carcinoma. Cancer Res., 51, 89-93 (1991).
10. Simon, D., Knowles, B. B. and Weith, A. Abnormalities of chromosome 1 and loss of heterozygosity of 1p in primary hepatomas. Oncogene, 6, 765-770 (1991).
11. Emi, M., Fujiwara, Y., Nakajima, T., Tsuchiya, E., Tsuda, H., Hirohashi, S., Maeda, Y., Tsuruta, K., Miyaki, M. and Nakamura, Y. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res., 52, 5368-5372 (1992).
12. Emi, M., Fujiwara, Y., Ohata, H., Tsuda, H., Hirohashi, S., Koike, M., Miyaki, M., Monden, M. and Nakamura, Y. Allelic loss at chromosome band 8p21.3-p22 is associated with progression of hepatocellular carcinoma. Gene Chrom. Cancer, 7, 152-157 (1993).
13. Murakami, Y., Hayashi, K., Hirohashi, S. and Sekiya, T. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res., 51, 5520-5525 (1991).
14. Oda, T., Tsuda, H., Scarpa, A., Sakamoto, M. and Hirohashi, S. Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma. Cancer Res., 52, 3674-3678 (1992).
15. Oda, T., Tsuda, H., Scarpa, A., Sakamoto, M. and Hirohashi, S. p53 gene mutation spectrum in hepatocellular carcinoma. Cancer Res., 52, 6358-6364 (1992).
16. Oda, T., Tsuda, H., Sakamoto, M. and Hirohashi, S. Different mutation of the p53 gene in nodule-in-nodule hepatocellular carcinoma as evidence for multistage progression. Cancer Lett., 83, 197-200 (1994).
17. Jones, P. A. and Buckley, J. D. The role of DNA methylation in cancer. Adv. Cancer Res., 54, 1-23 (1990).
18. Counts, J. L. and Goodman, J. I. Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell, 83, 13-15 (1995).
19. Gama-Sosa, M. A., Slagel, V. A., Trewyn, R. W., Oxenhandler, R., Kuo, K. C., Gehrke, C. W. and Ehrlich, M. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res., 11, 6883-6894 (1983).
20. Goelz, S. E., Vogelstein, B., Hamilton, S. R. and Feinberg, A. P. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science, 228, 189-190 (1985).
21. Kautiainen, T. L. and Jones, P. A. DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture. J. Biol. Chem., 261, 1594-1598 (1986).
22. El-Deiry, W. S., Nelkin, B. D., Celano, P., Yen, R.-W. C., Falco, J. P., Hamilton, S. R. and Baylin, S. B. High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc. Natl. Acad. Sci. USA, 88, 3470-3474 (1991).
23. Bustros, A. D., Nelkin, B. D., Silverman, A., Ehrlich, G., Poiesz, B. and Baylin, S. B. The short arm of chromosome 11 is a "hot spot" for hypermethylation in human neoplasia. Proc. Natl. Acad. Sci. USA, 85, 5693-5697 (1988).
24. Makos, M., Nelkin, B. D., Lerman, M. I., Latif, F., Zbar, B. and Baylin, S. B. Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc. Natl. Acad. Sci. USA, 89, 1929-1933 (1992).
25. Makos, M., Nelkin, B. D., Reiter, R. E., Gnarra, J. R., Brooks, J., Isaacs, W., Linehan, M. and Baylin, S. B. Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors. Cancer Res., 53, 2719-2722 (1993).
26. Pieretti, M., Powell, D. E., Gallion, H. H., Conway, P. S., Case, E. A. and Turker, M. S. Hypermethylation at a chromosome 17 "hot spot" is a common event in ovarian cancer. Hum. Pathol. 26, 398-401 (1995).
27. Makos, M., Nelkin, B. D., Chazin, V. R., Cavenee, W. K., Brodeur, G. M. and Baylin, S. B. DNA hypermethylation is associated with 17p allelic loss in neural tumors. Cancer Res., 53, 2715-2718 (1993).
28. Buchhagen, D. L., Qiu, L. and Etkind, P. Homozygous deletion, rearrangement and hypermethylation implicate chromosome region 3p14.3-3p21.3 in sporadic breastcancer development. Int. J. Cancer, 57, 473-479 (1994).
29. Vachtenheim, J., Horakova, I. and Novotna, H. Hypomethylation of CCGG sites in the 3′ region of K-ras protooncogene is frequent and is associated with K-ras allelic loss in non-small cell lung cancer. Cancer Res., 54, 1145-1148 (1994).
30. Shen, J.-C, Rideout III, W. M. and Jones, P. A. High frequency mutagenesis by a DNA methyltransferase. Cell, 71, 1073-1080 (1992).
31. Yang, A. S., Shen, J.-C., Zingg, J.-M., Mi, S. and Jones, P. A. HhaI and HpaII DNA methyltransferases bind DNA mismatches, methylate uracil and block DNA repair. Nucleic Acids Res., 23, 1380-1387 (1995).
32. Antequera, F., Boyes, J. and Bird, A. High levels of de nova methylation and altered chromatin structure at CpG islands in cell lines. Cell, 62, 503-514 (1990).
33. Bird, A. P. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Nature, 321, 209-213 (1986).
34. Keshet, I., Lieman-Hurwitz, J. and Cedar, H. DNA methylation affects the formation of active chromatin. Cell, 44, 535-543 (1986).
35. Edmondson, H. and Steiner, P. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer, 7, 462-503 (1954).
36. Sambrook, J., Fritsch, E. F. and Maniatis, T. "Molecular Cloning: a Laboratory Manual," pp. E.3-E.4 (1989). Cold Spring Harbor Lab., NY.
37. Harris, P., Lalande, M., Stroh, H., Bruns, G., Flint, A. and Latt, S. A. A. Construction of a chromosome 16-enriched phage library and characterization of several DNA segments from 16p. Hum. Genet., 77, 95-103 (1987).
38. Hyland, V. J., Grist, G. and Sutherland, G. R. Restriction fragment length polymorphisms detected by anonymous DNA probes mapped to defined intervals of human chromosome 16. Hum. Genet., 79, 277-279 (1988).
39. Westphal, E.-M., Natt, E., Grimm, T., Odievre, M. and Scherer, G. The human tyrosine aminotransferase gene: characterization of restriction fragment length polymorphisms and haplotype analysis in a family with tyrosinemia type II. Hum. Genet., 79, 260-264 (1988).
40. Bufton, L., Mohandas, T. K., Magenis, R. E., Sheehy, R., Bestwick, R. K. and Litt, M. A highly polymorphic locus on chromosome 16q revealed by a probe from a chromosome-specific cosmid library. Hum. Genet., 74, 425-431 (1986).
41. Doggett, N. A., Goodwin, L. A., Tesmer, J. G., Meincke, L. J., Bruce, D. C., Clark, L. M., Altherr, M. R., Ford, A. A., Chi, H. C., Marrone, B. L., Longmire, J. L., Lane, S. A., Whitmore, S. A., Lowenstein, M. G., Sutherland, R. D., Mundt, M. O., Knill, E. H., Bruno, W. J., Macken, C. A., Torney, D. C., Wu, J.-R., Griffith, J., Sutherland, G. R., Deaven, L. L., Callen, D. F. and Moyzis, R. K. An integrated physical map of human chromosome 16. Nature, 377, 335-364 (1995).
42. van der Ploeg, L. H. T. and Flavell, R. A. DNA methylation in the human γδβ-globin locus in erythroid and non-erythroid tissue. Cell, 19, 947-958 (1980).
43. Devilee, P., Vliet, M. V., Sloun, P. V., Dijkshoorn, N. K., Hermans, J., Pearson, P. L. and Cornelisse, C. J. Allelo-type of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. Oncogene, 6, 1705-1711 (1991).
44. Cleton-Jansen, A. M., Moerland, E. W., Kuipers-Dijkshoorn, N. J., Callen, D. F., Sutherland, G. R., Hansen, B., Devilee, P. and Cornelisse, C. At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer. Genes Chrom. Cancer, 9, 101-107 (1994).
45. Sakai, T., Toguchida, J., Ohtani, N., Yandell, D. W., Rapaport, J. M. and Dryja, T. P. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am. J. Hum. Genet., 48, 880-888 (1991).
46. Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D.-S. R., Gnarra, J. R., Linehan, W. M. and Baylin, S. B. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA, 91, 9700-9704 (1994).
47. INK4B1. Cancer Res., 56, 722-727 (1996).
48. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B. and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1, 686-692 (1995).
49. Herman, J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J.-P. J., Davidson, N. E., Sidransky, D. and Baylin, S. B. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55, 4525-4530 (1995).
50. Yoshiura, K., Kanai, Y., Ochiai, A., Shimoyama, Y., Sugimura, T. and Hirohashi, S. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc. Natl. Acad. Sci. USA, 92, 7416-7419 (1995).
51. Wales, M. M., Biel, M. A., Deiry, W. E., Nelkin, B. D., Issa, J.-P., Cavenee, W. K., Kuerbitz, S. J. and Baylin, S. B. p53 activates expression of HIC-1, a new candidate tumor suppressor gene on 17p13.3. Nat. Med., 1, 570-577 (1995).
52. Feinberg, A. P. and Vogelstein, B. Hypomethylation of ras oncogenes in primary human cancers. Biochem. Biophys. Res. Commun., 111, 47-54 (1983).
53. Cheah, M. S. C., Wallace, C. D. and Hoffman, R. M. Hypomethylation of DNA in human cancer cells: a site-specific change in the c-myc oncogene. J. Natl. Cancer Inst., 73, 1057-1065 (1984).
54. Laird, P. W., Jackson-Grusby, L., Fazeli, A., Dickinson, S. L., Jung, W. E., Li, E., Weinberg, R. A. and Jaenisch, R. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81, 197-205 (1995).
55. Grossmann, M., Hoermann, R., Weiss, M., Jauch, K. W., Oertel, H., Staebler, A., Mann, K. and Engelhardt, D. Spontaneous regression of hepatocellular carcinoma. Am. J. Gastroenterol., 90, 1500-1503 (1995).